Incidence, risk and prognostic role of anti-epidermal growth factor receptor-induced skin rash in biliary cancer: a meta-analysis.
Fangqiang WeiDonghun ShinXiu-Jun CaiPublished in: International journal of clinical oncology (2017)
Anti-EGFR treatment correlates with an increased risk of skin rash in advanced biliary cancer. Stratifying patients by the severity of rash may have major implications for survival benefit regarding anti-EGFR treatment for biliary cancer.
Keyphrases
- epidermal growth factor receptor
- papillary thyroid
- tyrosine kinase
- small cell lung cancer
- squamous cell
- advanced non small cell lung cancer
- end stage renal disease
- newly diagnosed
- risk factors
- squamous cell carcinoma
- ejection fraction
- chronic kidney disease
- lymph node metastasis
- childhood cancer
- patient reported outcomes
- drug induced
- wound healing
- smoking cessation